Wireless Telecom Group (AMEX:WTT) reported quarterly losses of $(0.04) per share which met the analyst consensus estimate. The company reported quarterly sales of $6.07 million which missed the analyst consensus estimate of $7.54 million by 19.52 percent. This is a 49.53 percent decrease over sales of $12.02 million the same period last year.
INmune Bio Reports Combination Therapy With INB03™ Overcomes Resistance To Trastuzumab-Deruxtecan In MUC4 Expressing HER2+ Breast Cancer
Neutralizing soluble TNF with INB03™ overcomes resistance to trastuzumab-deruxtecan in MUC4 expressing HER2+breast cancer.
Combination therapy of INB03™ and trastuzumab-deruxtecan presented at the 45th
